Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?

Abstract Background The use of hyperoncotic albumin (HA) for shock resuscitation is controversial given concerns about its cost, effectiveness, and potential for nephrotoxicity. We evaluated the association between early exposure to hyperoncotic albumin (within the first 48 h of onset of shock) and...

Full description

Bibliographic Details
Main Authors: Chiedozie I. Udeh, Jing You, Matthew R. Wanek, Jarrod Dalton, Belinda L. Udeh, Sevag Demirjian, Nadeem Rahman, J. Steven Hata
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Perioperative Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13741-018-0110-y
id doaj-b4666585eebe4635a58e34d9e4ea278e
record_format Article
spelling doaj-b4666585eebe4635a58e34d9e4ea278e2020-11-25T02:07:40ZengBMCPerioperative Medicine2047-05252018-12-017111110.1186/s13741-018-0110-yAcute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?Chiedozie I. Udeh0Jing You1Matthew R. Wanek2Jarrod Dalton3Belinda L. Udeh4Sevag Demirjian5Nadeem Rahman6J. Steven Hata7Center for Critical Medicine, Anesthesiology InstituteDepartment of Special Line Product Development, Progressive InsuranceDepartment of Inpatient Pharmacy, Cleveland Clinic Pharm DDepartment of Quantitative Health Sciences, Lemer Research Institute, Cleveland ClinicDepartment of Quantitative Health Sciences, Lemer Research Institute, Cleveland ClinicDepartment of Nephrology, Glickman Urology and Kidney Institute, Cleveland ClinicCritical Care Institute, Cleveland ClinicCenter for Critical Medicine, Anesthesiology InstituteAbstract Background The use of hyperoncotic albumin (HA) for shock resuscitation is controversial given concerns about its cost, effectiveness, and potential for nephrotoxicity. We evaluated the association between early exposure to hyperoncotic albumin (within the first 48 h of onset of shock) and acute organ dysfunction in post-surgical patients with shock. Methods This retrospective, cohort study included 11,512 perioperative patients with shock from 2009 to 2012. Shock was defined as requirement for vasopressors to maintain adequate mean arterial pressure and/or elevated lactate (> 2.2 mmol/L). Subsets of 3600 were selected after propensity score and exact matching on demographics, comorbidities, and treatment variables (> 30). There was a preponderance of cardiac surgery patients. Proportional odds logistic regression, multivariable logistic regression or Cox proportional hazard regression models measured association between hyperoncotic albumin and acute kidney injury (AKI), hepatic injury, ICU days, and mortality. Results Hyperoncotic albumin-exposed patients showed greater risk of acute kidney injury compared to controls (OR 1.10, 95% CI 1.04, 1.17. P = 0.002), after adjusting for imbalanced co-variables. Within matched patients, 20.3%, 2.9%, and 4.4% of HA patients experienced KDIGO stages 1–3 AKI, versus 19.6%, 2.5%, and 3.0% of controls. There was no difference in hepatic injury (OR 1.16; 98.3% CI 0.85, 1.58); ICU days, (HR 1.05; 98.3% CI 1.00, 1.11); or mortality, (OR 0.88; 98.3% CI 0.64, 1.20). Conclusions Early exposure to hyperoncotic albumin in postoperative shock appeared to be associated with acute kidney injury. There did not appear to be any association with hepatic injury, mortality, or ICU days. The clinical and economic implications of this finding warrant further investigation.http://link.springer.com/article/10.1186/s13741-018-0110-y(National Library of Medicine-Medical Subject Headings): AlbuminResuscitationAcute kidney injuryShockMultiple organ failure
collection DOAJ
language English
format Article
sources DOAJ
author Chiedozie I. Udeh
Jing You
Matthew R. Wanek
Jarrod Dalton
Belinda L. Udeh
Sevag Demirjian
Nadeem Rahman
J. Steven Hata
spellingShingle Chiedozie I. Udeh
Jing You
Matthew R. Wanek
Jarrod Dalton
Belinda L. Udeh
Sevag Demirjian
Nadeem Rahman
J. Steven Hata
Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
Perioperative Medicine
(National Library of Medicine-Medical Subject Headings): Albumin
Resuscitation
Acute kidney injury
Shock
Multiple organ failure
author_facet Chiedozie I. Udeh
Jing You
Matthew R. Wanek
Jarrod Dalton
Belinda L. Udeh
Sevag Demirjian
Nadeem Rahman
J. Steven Hata
author_sort Chiedozie I. Udeh
title Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
title_short Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
title_full Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
title_fullStr Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
title_full_unstemmed Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
title_sort acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
publisher BMC
series Perioperative Medicine
issn 2047-0525
publishDate 2018-12-01
description Abstract Background The use of hyperoncotic albumin (HA) for shock resuscitation is controversial given concerns about its cost, effectiveness, and potential for nephrotoxicity. We evaluated the association between early exposure to hyperoncotic albumin (within the first 48 h of onset of shock) and acute organ dysfunction in post-surgical patients with shock. Methods This retrospective, cohort study included 11,512 perioperative patients with shock from 2009 to 2012. Shock was defined as requirement for vasopressors to maintain adequate mean arterial pressure and/or elevated lactate (> 2.2 mmol/L). Subsets of 3600 were selected after propensity score and exact matching on demographics, comorbidities, and treatment variables (> 30). There was a preponderance of cardiac surgery patients. Proportional odds logistic regression, multivariable logistic regression or Cox proportional hazard regression models measured association between hyperoncotic albumin and acute kidney injury (AKI), hepatic injury, ICU days, and mortality. Results Hyperoncotic albumin-exposed patients showed greater risk of acute kidney injury compared to controls (OR 1.10, 95% CI 1.04, 1.17. P = 0.002), after adjusting for imbalanced co-variables. Within matched patients, 20.3%, 2.9%, and 4.4% of HA patients experienced KDIGO stages 1–3 AKI, versus 19.6%, 2.5%, and 3.0% of controls. There was no difference in hepatic injury (OR 1.16; 98.3% CI 0.85, 1.58); ICU days, (HR 1.05; 98.3% CI 1.00, 1.11); or mortality, (OR 0.88; 98.3% CI 0.64, 1.20). Conclusions Early exposure to hyperoncotic albumin in postoperative shock appeared to be associated with acute kidney injury. There did not appear to be any association with hepatic injury, mortality, or ICU days. The clinical and economic implications of this finding warrant further investigation.
topic (National Library of Medicine-Medical Subject Headings): Albumin
Resuscitation
Acute kidney injury
Shock
Multiple organ failure
url http://link.springer.com/article/10.1186/s13741-018-0110-y
work_keys_str_mv AT chiedozieiudeh acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT jingyou acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT matthewrwanek acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT jarroddalton acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT belindaludeh acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT sevagdemirjian acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT nadeemrahman acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
AT jstevenhata acutekidneyinjuryinpostoperativeshockishyperoncoticalbuminadministrationanunrecognizedresuscitationriskfactor
_version_ 1724930434549153792